Antitumor Effects of Six Ricin A-Chain Immunotoxins of Potential Use in the Treatment of Hodgkin’S Disease
The fate of patients with Hodgkin’s disease who relapse or fail to achieve complete remission with first line treatment is ominous. Second line combination chemotherapy can produce good remission rates although cures are uncommon (Hagemeister et al, 1987; Santoro et al, 1986). Of those patients achieving complete remissions, 15–20% will develop a second malignancy as a chemotherapy-related side effect (Valagussa et al, 1986). Therefore new non-mutagenic agents are needed for the treatment of this disease.
KeywordsL540 Cell Growth Index LS40 Cell Interdigitating Reticulum Cell Imperial Cancer Research Fund
Unable to display preview. Download preview PDF.
- Bernhard, M.I., Foon, K.A., Oeltmann, T.N., Key, M.E., Hwang, K.M., Clarke, G.C., Christensen, W.L., Hoyer, L.C., Hanna, M.G., Jr. and Oldham, R.K., 1983, Guinea pig line 10 hepatocarcinoma model: characterization of monoclonal antibody and in vivo effect of unconjugated antibody and antibody conjugated to diphtheria toxin A-chain, Cancer Res. 43:4420.PubMedGoogle Scholar
- Engert, A., Burrows, F., Jung, W., Tazzari, P.L., Stein, H., Pfreundschuh, M., Diehl, V. and Thorpe, P., 1990, Evaliiation of ricin A-chain- containing immunotoxins directed against CD30 as potential reagents for the treatment of Hodgkin’s disease. Cancer Res., in press.Google Scholar
- Hagemeister, F.B., Tannir, N., McLaughlin, P., Salvador, P., Riggs, S., Velasquez, W.S. and Cabanillas, F., 1987, MIME chemotherapy (Methyl- GAG, Ifosfamide, Methothrexate, Etoposide) as treatment for recurrent Hodgkin’s disease, Clin.Oncol., 5:556.Google Scholar
- Hsu, S-M., Ho, Y-S. and Hsu, P-L., 1987, Effect of monoclonal antibodies anti-2H9, anti-IRac, and anti-HeFi-1 on the surface antigens of Reed-Stemberg cells, J.Natl.Cancer Inst., 5:1091.Google Scholar
- Schwarting, R., Gerdes, J. and Stein, H., 1987, Ber-H2: a new monoclonal antibody of the Ki-1 family for the detection of Hodgkin’s disease in formaldehyde-fixed tissue sections, to: “Leucocyte Typing III”, J.A. McMichael, ed., Oxford University Press, Oxford.Google Scholar
- Stein, H., Mason, D.Y., Gerdes, J., O’Connor, N., Wainscoat, J., Pallesen, G., Gatter, K., Falini, B., Delsol, G., Lembke, H., Schwarting, R. and Lennert, K., 1985, The expression of the Hodgkin’s disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Stemberg-Reed cells and histiocytic malignancies are derived from activated lymphoid cells. Blood, 66:848.PubMedGoogle Scholar
- Thorpe, P.E., Detre, S.I., Foxwell, B.M.J., Brown, A.N.F., Skilleter, D.N, Wilson, G., Forrester, J.A. and Stirpe, F., 1985, Modification of the carbohydrate in ricin with me taper iodate-cyanoborohydride mixtures. Effect on toxicity and in vivo distribution, Eur. J.Biochem., 147:197.PubMedCrossRefGoogle Scholar
- Thorpe, P.E., Wallace, P.M., Knowles, P.P. Reif, M.G., Brown, A.N.F., Watson, G.J., Knyba, R.E., Wawrzamczak, E.J. and Blakey, D.C., 1987, New coupling agents for the synthesis of immunotoxins containing a hindered disulfide bond with improved stability in vivo, Cancer Res., 47:5924.PubMedGoogle Scholar